Denali Therapeutics (DNLI) Depreciation and Depletion (2017 - 2018)
Denali Therapeutics (DNLI) posted quarterly Depreciation and Depletion of $2.3 million for Q3 2018, up 199.1% year-over-year from $778000.0 in Q3 2017, and up 25.44% quarter-over-quarter from $1.9 million in Q2 2018.
Denali Therapeutics (DNLI) Depreciation and Depletion (2017 - 2018) Analysis & Trends
Denali Therapeutics (DNLI) has reported Depreciation and Depletion for 2 consecutive years, with $2.3 million the latest figure, recorded in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 2.33 Mn |
| Sep 30, 2018 | 2.33 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Mar 31, 2018 | 854,000.00 |
| Mar 31, 2018 | 854,000.00 |
| Sep 30, 2017 | 778,000.00 |
| Sep 30, 2017 | 778,000.00 |
| Jun 30, 2017 | 766,000.00 |
| Jun 30, 2017 | 766,000.00 |
| Mar 31, 2017 | 731,000.00 |
| Mar 31, 2017 | 731,000.00 |